Synopsis
Synopsis
0
EU WC
0
KDMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Sulfadiazine, Zinc
2. Sulfazin
3. Sulfazine
4. Sulphadiazine
5. Zinc Sulfadiazine
1. 68-35-9
2. Sulphadiazine
3. Sulfapyrimidine
4. Sulfadiazin
5. Adiazine
6. Sulfazine
7. Sulfadiazene
8. Adiazin
9. Debenal
10. Pyrimal
11. Liquadiazine
12. Sulfapyrimidin
13. 2-sulfanilamidopyrimidine
14. Coco-diazine
15. Cremodiazine
16. Spofadrizine
17. Theradiazine
18. Cremotres
19. Deltazina
20. Diazolone
21. Eskadiazine
22. Microsulfon
23. Neotrizine
24. Palatrize
25. Piridisir
26. Quadetts
27. Quadramoid
28. Sanodiazine
29. Sterazine
30. Sulfatryl
31. Sulfolex
32. Sulfonsol
33. Terfonyl
34. Trifonamide
35. Truozine
36. Diazin
37. Neazine
38. Pirimal
39. Sulfose
40. Trisem
41. Sulfanilamidopyrimidine
42. Honey Diazine
43. Lipo-levazine
44. Tri-sulfameth
45. Triple Sulfas
46. Lipo-diazine
47. Metha-meridiazine
48. Sulfadiazinum
49. Diazovit
50. Sulfadiazina
51. Sulphadiazine E
52. 4-amino-n-(pyrimidin-2-yl)benzenesulfonamide
53. Sulfapirimidin
54. Di-azo-mul
55. Thi-di-mer
56. 2-sulfanilylaminopyrimidine
57. Benzenesulfonamide, 4-amino-n-2-pyrimidinyl-
58. Codiazine
59. Silvadene
60. Pecta-diazine, Suspension
61. 4-amino-n-pyrimidin-2-ylbenzenesulfonamide
62. Rp 2616
63. Pyrimidine, 2-sulfanilamido-
64. 2-sulfapyrimidine
65. N(1)-2-pyrimidylsulfanilamide
66. N(1)-2-pyrimidinylsulfanilamide
67. 4-amino-n-2-pyrimidinylbenzenesulfonamide
68. N(sup 1)-2-pyrimidinylsulfanilamide
69. 4-amino-n-(pyrimidin-2-yl)benzene-1-sulfonamide
70. Sulfanilamide, N1-2-pyrimidinyl-
71. 4-amino-n-pyrimidin-2-yl-benzenesulfonamide
72. Chebi:9328
73. Sulfanilamide, N(sup 1)-2-pyrimidinyl-
74. 4-amino-n-2-pyrimidinyl-benzenesulfonamide
75. N(sup1)-2-pyrimidylsulfanilamide
76. Sulfanilamide, N1-2(1h)-pyrimidinylidene-
77. Silver Sulfadiazine
78. A-306
79. N(sup1)-2-pyrimidinylsulfanilamide
80. Chembl439
81. S. N. 112
82. Nsc35600
83. Nsc-35600
84. Cas-68-35-9
85. Ncgc00016305-01
86. Solfadiazina
87. Cocodiazine
88. Solfadiazina [dcit]
89. Sulfadiazine 100 Microg/ml In Acetonitrile
90. 0n7609k889
91. 2-sulfanilamidopyrimidin
92. Nsc117870
93. Sulfapyrimidin [german]
94. Sdz
95. Sulfadiazinum [inn-latin]
96. Sulfadiazina [inn-spanish]
97. Sildaflo
98. S.n. 112
99. 2-sulfanilamidopyrimidin [german]
100. A-306 (van)
101. 4-amino-n-(2-pyrimidinyl)benzenesulfonamide
102. A 306
103. Smr000059113
104. Sulfadiazine (tn)
105. N-(2-pyrimidinyl)sulfanilamide
106. Rbpi21 & Sulfa
107. Rp-2616
108. Sr-01000002973
109. Ssd
110. Einecs 200-685-8
111. Mfcd00006065
112. Nsc 35600
113. 2-sulfanilamido-pyrimidine
114. Brn 0235192
115. Diazine
116. Crl-8131 & Sulfadiazine
117. N1-2-pyrimidinylsulfanilamide
118. Sulfadiazine (jan/usp/inn)
119. Ai3-01047
120. Sulfadiazine,(s)
121. Trisulfapyrimidine, Oral Suspension
122. Unii-0n7609k889
123. Sulfadiazine [usp:inn:ban:jan]
124. Prestwick_428
125. Spectrum_000986
126. Sulfadiazina Reig Jofre
127. Sulfacombin (salt/mix)
128. Prestwick0_000023
129. Prestwick1_000023
130. Prestwick2_000023
131. Prestwick3_000023
132. Spectrum2_001319
133. Spectrum3_001362
134. Spectrum4_000342
135. Spectrum5_000992
136. Sulfadiazine [mi]
137. [(4-aminophenyl)sulfonyl]pyrimidin-2-ylamine
138. Sulfadiazine [inn]
139. Sulfadiazine [jan]
140. Epitope Id:140083
141. N1-2-pyrimidylsulfanilamide
142. Sulfadiazine, >=99.0%
143. Dsstox_cid_24130
144. Dsstox_rid_80105
145. Sulfadiazine [vandf]
146. Dsstox_gsid_44130
147. Oprea1_081078
148. Schembl24176
149. Bspbio_000085
150. Bspbio_002884
151. Kbiogr_000743
152. Kbioss_001466
153. Sulfadiazine [mart.]
154. 5-25-10-00067 (beilstein Handbook Reference)
155. Mls000069423
156. Mls006011457
157. Divk1c_000543
158. Spectrum1500546
159. Sulfadiazine [usp-rs]
160. Sulfadiazine [who-dd]
161. Spbio_001417
162. Spbio_002006
163. Bpbio1_000095
164. Wln: T6n Cnj Bmswr Dz
165. Dtxsid7044130
166. Hms501l05
167. Kbio1_000543
168. Kbio2_001466
169. Kbio2_004034
170. Kbio2_006602
171. Kbio3_002104
172. Sulfadiazine [green Book]
173. Ninds_000543
174. Glxc-25873
175. Hms1568e07
176. Hms1921a13
177. Hms2090p09
178. Hms2092i15
179. Hms2095e07
180. Hms2235d19
181. Hms3371l19
182. Hms3655i10
183. Hms3712e07
184. Pharmakon1600-01500546
185. Sulfadiazine [orange Book]
186. Zinc120319
187. Sulfadiazine [ep Monograph]
188. Sulfadiazine [usp Impurity]
189. Albb-014888
190. Amy33423
191. Bcp12140
192. Hy-b0273
193. Sulfadiazine [usp Monograph]
194. Tox21_110360
195. Bbl013169
196. Bdbm50166571
197. Ccg-39257
198. Nsc757324
199. Recombinant Bactericidal/permeability-increasing Protein & Sulfadiazine
200. S1770
201. Stk317797
202. Sulfose Component Sulfadiazine
203. Terfonyl Component Sulfadiazine
204. 2-(p-aminobenzenesulfonamido)pyrimidin
205. Akos000119073
206. Lantrisul Component Sulfadiazine
207. Sulfaloid Component Sulfadiazine
208. Db00359
209. Ks-1144
210. Nsc-757324
211. Sulfadiazin 100 Microg/ml In Methanol
212. 2-(4-aminobenzenesulfonamido)pyrimidine
213. 4-amino-n-2-pyrimidylbenzenesulfonamide
214. Idi1_000543
215. Neotrizine Component Sulfadiazine
216. Sulfadiazine Component Of Sulfose
217. Ncgc00016305-02
218. Ncgc00016305-03
219. Ncgc00016305-04
220. Ncgc00016305-05
221. Ncgc00016305-06
222. Ncgc00016305-09
223. Ncgc00016305-10
224. Ncgc00016305-11
225. Ncgc00023291-03
226. Ncgc00023291-04
227. Sulfadiazine (trisulfapyrimidines)
228. Sulfadiazine Component Of Terfonyl
229. Trisulfapyrimidines (sulfadiazine)
230. 2-(4-aminobenzenesulfonylamino)pyrimidine
231. Ac-26817
232. Sulfadiazine 1000 Microg/ml In Methanol
233. Sulfadiazine Component Of Lantrisul
234. Sulfadiazine Component Of Sulfaloid
235. 4-amino-n-2-pyrimidinyl Benzenesulfonamide
236. Mixture Of Sulfadiazine, And Sulfamethazine
237. Sbi-0051520.p003
238. Sulfadiazine Component Of Neotrizine
239. Triple Sulfoid Component Sulfadiazine
240. 4-[[(pyrimidin-2-yl)amino]sulfonyl]aniline
241. Ab00052095
242. Benzenesulfonamide,4-amino-n-2-pyrimidinyl-
243. Ft-0674739
244. Ft-0674740
245. Ft-0674741
246. S0579
247. Sulfadiazine For Identification Of Impurity F
248. Sw196657-3
249. 4-amino-n-(2-pyrimidinyl) Benzenesulfonamide
250. Sulfadimidine Impurity B [ep Impurity]
251. 4-amino-n-(2-pyrimidinyl)benzenesulfonamide #
252. 68s359
253. C07658
254. D00587
255. D92267
256. Sulfadiazine Component Of Triple Sulfoid
257. Trisulfapyrimidine, Oral Suspension (salt/mix)
258. Ab00052095-13
259. Ab00052095-14
260. Ab00052095_15
261. Ab00052095_16
262. Benzenesulfonamide, 4-amino-n-(2-pyrimidinyl)-
263. Sulfadiazine, Vetranal(tm), Analytical Standard
264. Sulfonamides Duplex Component Sulfadiazine
265. A836115
266. Q-201759
267. Q2555060
268. Sr-01000002973-2
269. Sr-01000002973-3
270. Sulfadiazine Component Of Sulfonamides Duplex
271. Brd-k32273377-001-05-4
272. Brd-k32273377-001-09-6
273. F1657-1720
274. Sulfadiazine, Certified Reference Material, Tracecert(r)
275. Trisulfapyrimidines (sulfadiazine) [orange Book]
276. Z271004844
277. Sulfadiazine, European Pharmacopoeia (ep) Reference Standard
278. Sulfadiazine, United States Pharmacopeia (usp) Reference Standard
279. 4-amino-n-(2-pyrimidinyl)benzenesulfonamide, N1-(pyrimidin-2-yl)sulfanilamide
280. Sulfadiazine, Pharmaceutical Secondary Standard; Certified Reference Material
281. 141582-64-1
282. Sulfadiazine For Identification Of Impurity F, European Pharmacopoeia (ep) Reference Standard
1. Sulfadiazine Sodium
2. Sodium Sulfadiazine
3. Sodium Sulfapyrimidine
| Molecular Weight | 250.28 g/mol |
|---|---|
| Molecular Formula | C10H10N4O2S |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 250.05244675 g/mol |
| Monoisotopic Mass | 250.05244675 g/mol |
| Topological Polar Surface Area | 106 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 327 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 8 | |
|---|---|
| Drug Name | Silvadene |
| PubMed Health | Silver Sulfadiazine (On the skin) |
| Drug Classes | Antibacterial |
| Active Ingredient | Silver sulfadiazine |
| Dosage Form | Cream |
| Route | Topical |
| Strength | 1% |
| Market Status | Prescription |
| Company | King Pharms |
| 2 of 8 | |
|---|---|
| Drug Name | Ssd |
| PubMed Health | Sulfadiazine (By mouth) |
| Drug Classes | Antibiotic |
| Active Ingredient | Silver sulfadiazine |
| Dosage Form | Cream |
| Route | Topical |
| Strength | 1% |
| Market Status | Prescription |
| Company | Dr Reddys La |
| 3 of 8 | |
|---|---|
| Drug Name | Sulfadiazine |
| PubMed Health | Silver Sulfadiazine (On the skin) |
| Drug Classes | Antibacterial |
| Drug Label | Sulfadiazine is an oral sulfonamide anti-bacterial agent.Each tablet, for oral administration, contains 500 mg sulfadiazine. In addition, each tablet contains the following inactive ingredients: croscarmellose sodium, docusate sodium, microcrystallin... |
| Active Ingredient | Sulfadiazine |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 500mg |
| Market Status | Prescription |
| Company | Sandoz |
| 4 of 8 | |
|---|---|
| Drug Name | Thermazene |
| Active Ingredient | Silver sulfadiazine |
| Dosage Form | Cream |
| Route | Topical |
| Strength | 1% |
| Market Status | Prescription |
| Company | Thepharmanetwork |
| 5 of 8 | |
|---|---|
| Drug Name | Silvadene |
| PubMed Health | Silver Sulfadiazine (On the skin) |
| Drug Classes | Antibacterial |
| Active Ingredient | Silver sulfadiazine |
| Dosage Form | Cream |
| Route | Topical |
| Strength | 1% |
| Market Status | Prescription |
| Company | King Pharms |
| 6 of 8 | |
|---|---|
| Drug Name | Ssd |
| PubMed Health | Sulfadiazine (By mouth) |
| Drug Classes | Antibiotic |
| Active Ingredient | Silver sulfadiazine |
| Dosage Form | Cream |
| Route | Topical |
| Strength | 1% |
| Market Status | Prescription |
| Company | Dr Reddys La |
| 7 of 8 | |
|---|---|
| Drug Name | Sulfadiazine |
| PubMed Health | Silver Sulfadiazine (On the skin) |
| Drug Classes | Antibacterial |
| Drug Label | Sulfadiazine is an oral sulfonamide anti-bacterial agent.Each tablet, for oral administration, contains 500 mg sulfadiazine. In addition, each tablet contains the following inactive ingredients: croscarmellose sodium, docusate sodium, microcrystallin... |
| Active Ingredient | Sulfadiazine |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 500mg |
| Market Status | Prescription |
| Company | Sandoz |
| 8 of 8 | |
|---|---|
| Drug Name | Thermazene |
| Active Ingredient | Silver sulfadiazine |
| Dosage Form | Cream |
| Route | Topical |
| Strength | 1% |
| Market Status | Prescription |
| Company | Thepharmanetwork |
For the treatment of rheumatic fever and meningococcal meningitis
Sulfadiazine is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Coccidiostats
Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)
Antiprotozoal Agents
Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)
J01EC02
S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448
J01EC02
S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448
D - Dermatologicals
D06 - Antibiotics and chemotherapeutics for dermatological use
D06B - Chemotherapeutics for topical use
D06BA - Sulfonamides
D06BA01 - Silver sulfadiazine
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01E - Sulfonamides and trimethoprim
J01EC - Intermediate-acting sulfonamides
J01EC02 - Sulfadiazine
Route of Elimination
Sulfadiazine is excreted largely in the urine.
Sulfadiazine has known human metabolites that include Sulfadiazine hydroxylamine.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Sulfadiazine is a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase. This enzyme is needed for the proper processing of para-aminobenzoic acid (PABA) which is essential for folic acid synthesis. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Disintegrants & Superdisintegrants
Granulation
Direct Compression
Thickeners and Stabilizers
Co-Processed Excipients
Coating Systems & Additives
Film Formers & Plasticizers
Solubilizers
Controlled & Modified Release
Lubricants & Glidants
Chewable & Orodispersible Aids
Taste Masking
Rheology Modifiers
Parenteral
Topical
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
69
PharmaCompass offers a list of Sulfadiazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulfadiazine manufacturer or Sulfadiazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulfadiazine manufacturer or Sulfadiazine supplier.
PharmaCompass also assists you with knowing the Sulfadiazine API Price utilized in the formulation of products. Sulfadiazine API Price is not always fixed or binding as the Sulfadiazine Price is obtained through a variety of data sources. The Sulfadiazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A N1-(Pyrimidin-2-yl)sulfanilamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N1-(Pyrimidin-2-yl)sulfanilamide, including repackagers and relabelers. The FDA regulates N1-(Pyrimidin-2-yl)sulfanilamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N1-(Pyrimidin-2-yl)sulfanilamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N1-(Pyrimidin-2-yl)sulfanilamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A N1-(Pyrimidin-2-yl)sulfanilamide supplier is an individual or a company that provides N1-(Pyrimidin-2-yl)sulfanilamide active pharmaceutical ingredient (API) or N1-(Pyrimidin-2-yl)sulfanilamide finished formulations upon request. The N1-(Pyrimidin-2-yl)sulfanilamide suppliers may include N1-(Pyrimidin-2-yl)sulfanilamide API manufacturers, exporters, distributors and traders.
click here to find a list of N1-(Pyrimidin-2-yl)sulfanilamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N1-(Pyrimidin-2-yl)sulfanilamide DMF (Drug Master File) is a document detailing the whole manufacturing process of N1-(Pyrimidin-2-yl)sulfanilamide active pharmaceutical ingredient (API) in detail. Different forms of N1-(Pyrimidin-2-yl)sulfanilamide DMFs exist exist since differing nations have different regulations, such as N1-(Pyrimidin-2-yl)sulfanilamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N1-(Pyrimidin-2-yl)sulfanilamide DMF submitted to regulatory agencies in the US is known as a USDMF. N1-(Pyrimidin-2-yl)sulfanilamide USDMF includes data on N1-(Pyrimidin-2-yl)sulfanilamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N1-(Pyrimidin-2-yl)sulfanilamide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N1-(Pyrimidin-2-yl)sulfanilamide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The N1-(Pyrimidin-2-yl)sulfanilamide Drug Master File in Japan (N1-(Pyrimidin-2-yl)sulfanilamide JDMF) empowers N1-(Pyrimidin-2-yl)sulfanilamide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the N1-(Pyrimidin-2-yl)sulfanilamide JDMF during the approval evaluation for pharmaceutical products. At the time of N1-(Pyrimidin-2-yl)sulfanilamide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of N1-(Pyrimidin-2-yl)sulfanilamide suppliers with JDMF on PharmaCompass.
A N1-(Pyrimidin-2-yl)sulfanilamide CEP of the European Pharmacopoeia monograph is often referred to as a N1-(Pyrimidin-2-yl)sulfanilamide Certificate of Suitability (COS). The purpose of a N1-(Pyrimidin-2-yl)sulfanilamide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of N1-(Pyrimidin-2-yl)sulfanilamide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of N1-(Pyrimidin-2-yl)sulfanilamide to their clients by showing that a N1-(Pyrimidin-2-yl)sulfanilamide CEP has been issued for it. The manufacturer submits a N1-(Pyrimidin-2-yl)sulfanilamide CEP (COS) as part of the market authorization procedure, and it takes on the role of a N1-(Pyrimidin-2-yl)sulfanilamide CEP holder for the record. Additionally, the data presented in the N1-(Pyrimidin-2-yl)sulfanilamide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the N1-(Pyrimidin-2-yl)sulfanilamide DMF.
A N1-(Pyrimidin-2-yl)sulfanilamide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. N1-(Pyrimidin-2-yl)sulfanilamide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of N1-(Pyrimidin-2-yl)sulfanilamide suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing N1-(Pyrimidin-2-yl)sulfanilamide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for N1-(Pyrimidin-2-yl)sulfanilamide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture N1-(Pyrimidin-2-yl)sulfanilamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain N1-(Pyrimidin-2-yl)sulfanilamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a N1-(Pyrimidin-2-yl)sulfanilamide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of N1-(Pyrimidin-2-yl)sulfanilamide suppliers with NDC on PharmaCompass.
N1-(Pyrimidin-2-yl)sulfanilamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N1-(Pyrimidin-2-yl)sulfanilamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N1-(Pyrimidin-2-yl)sulfanilamide GMP manufacturer or N1-(Pyrimidin-2-yl)sulfanilamide GMP API supplier for your needs.
A N1-(Pyrimidin-2-yl)sulfanilamide CoA (Certificate of Analysis) is a formal document that attests to N1-(Pyrimidin-2-yl)sulfanilamide's compliance with N1-(Pyrimidin-2-yl)sulfanilamide specifications and serves as a tool for batch-level quality control.
N1-(Pyrimidin-2-yl)sulfanilamide CoA mostly includes findings from lab analyses of a specific batch. For each N1-(Pyrimidin-2-yl)sulfanilamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N1-(Pyrimidin-2-yl)sulfanilamide may be tested according to a variety of international standards, such as European Pharmacopoeia (N1-(Pyrimidin-2-yl)sulfanilamide EP), N1-(Pyrimidin-2-yl)sulfanilamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N1-(Pyrimidin-2-yl)sulfanilamide USP).
